458 related articles for article (PubMed ID: 24726868)
1. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
2. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.
Macaluso FS; Caprioli F; Benedan L; Bezzio C; Caporali R; Cauli A; Chimenti MS; Ciccia F; D'Angelo S; Fantini MC; Festa S; Iannone F; Lubrano E; Mariani P; Papi C; Provenzano G; Pugliese D; Rispo A; Saibeni S; Salvarani C; Variola A; Zenga M; Armuzzi A; Orlando A; Gerli R
Autoimmun Rev; 2024 May; 23(5):103533. PubMed ID: 38521214
[TBL] [Abstract][Full Text] [Related]
3. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Bowel Diseases and Spondyloarthropathies.
Gionchetti P; Calabrese C; Rizzello F
J Rheumatol Suppl; 2015 Nov; 93():21-3. PubMed ID: 26523049
[TBL] [Abstract][Full Text] [Related]
5. SpA plus IBD or IBD plus SpA: Does commutative property apply?
Carubbi F; Alunno A; Viscido A; Baraliakos X; Mariani FM; Di Ruscio E; Altieri P; Ferri C
Autoimmun Rev; 2023 Oct; 22(10):103443. PubMed ID: 37678619
[TBL] [Abstract][Full Text] [Related]
6. Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis.
Felice C; Leccese P; Scudeller L; Lubrano E; Cantini F; Castiglione F; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Olivieri I; Armuzzi A;
Clin Exp Immunol; 2019 Apr; 196(1):123-138. PubMed ID: 30554407
[TBL] [Abstract][Full Text] [Related]
7. Management of patients with inflammatory bowel disease and spondyloarthritis.
Pouillon L; Bossuyt P; Vanderstukken J; Moulin D; Netter P; Danese S; Jouzeau JY; Loeuille D; Peyrin-Biroulet L
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1363-1374. PubMed ID: 28879780
[TBL] [Abstract][Full Text] [Related]
8. Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease.
Ben Nessib D; Ferjani H; Maatallah K; Rahmouni S; Kaffel D; Hamdi W
Clin Rheumatol; 2020 Dec; 39(12):3543-3553. PubMed ID: 32424656
[TBL] [Abstract][Full Text] [Related]
9. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
[TBL] [Abstract][Full Text] [Related]
10. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
Wang CR; Tsai HW
World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
[TBL] [Abstract][Full Text] [Related]
11. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
Subramaniam K; Tymms K; Shadbolt B; Pavli P
Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
[TBL] [Abstract][Full Text] [Related]
12. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study.
Ossum AM; Palm Ø; Cvancarova M; Solberg IC; Vatn M; Moum B; Høivik ML;
Scand J Gastroenterol; 2018; 53(10-11):1250-1256. PubMed ID: 30353756
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.
Salvarani C; Fries W
World J Gastroenterol; 2009 May; 15(20):2449-55. PubMed ID: 19468993
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician.
Lubrano E; Luchetti MM; Benfaremo D; Mauro D; Ciccia F; Perrotta FM
Expert Rev Clin Immunol; 2021 Nov; 17(11):1199-1209. PubMed ID: 34622735
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
Stolwijk C; Pierik M; Landewé R; Masclee A; van Tubergen A
Can J Gastroenterol; 2013 Apr; 27(4):199-205. PubMed ID: 23616957
[TBL] [Abstract][Full Text] [Related]
16. [Update: enterogenic spondylarthritis].
Märker-Hermann E
Z Rheumatol; 2021 Aug; 80(6):539-551. PubMed ID: 34046687
[TBL] [Abstract][Full Text] [Related]
17. Occult spondyloarthritis in inflammatory bowel disease.
Bandinelli F; Manetti M; Ibba-Manneschi L
Clin Rheumatol; 2016 Feb; 35(2):281-9. PubMed ID: 26354428
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts.
Armuzzi A; Felice C; Lubrano E; Cantini F; Castiglione F; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Marchesoni A; Vecchi M; Olivieri I;
Dig Liver Dis; 2017 Dec; 49(12):1298-1305. PubMed ID: 28822731
[TBL] [Abstract][Full Text] [Related]
20. Enteropathic spondyloarthritis: Results from a large nationwide database analysis.
Picchianti-Diamanti A; Lorenzetti R; Chimenti MS; Luchetti MM; Conigliaro P; Canofari C; Benfaremo D; Bruzzese V; Laganà B; Perricone R;
Autoimmun Rev; 2020 Feb; 19(2):102457. PubMed ID: 31838160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
